Shortened activated partial thromboplastin time, a hemostatic marker for hypercoagulable state during acute coronary event

Translational Research

Volumn 155, Issue 6, 2010, Pages 315-319

  Abdullah, Wan Zaidah ^a   Moufak, Shaimaa K ^a   Yusof, Zurkurnai ^a   Mohamad, Mohd Sapawi ^a   Kamarul, I M ^a  

^a SCHOOL OF MEDICAL SCIENCES   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 8;

ACUTE CORONARY SYNDROME; ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY THROMBOSIS; DISEASE MARKER; FEMALE; HUMAN; HYPERCOAGULABILITY; ISCHEMIC HEART DISEASE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALAYSIA; MALE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTHROMBIN TIME; REFERENCE VALUE; UNIVERSITY HOSPITAL;

EID: 77952107543     PISSN: 19315244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trsl.2010.02.001     Document Type: Article

References (10)

1. Fareed J., Hoppensteadt D.A., Leya F., Iqbal O., Wolf H., and Bick R. Useful laboratory tests for studying thrombogenesis in acute cardiac syndromes. Clin Chem 44 (1998) 1845-1853
2. Kamphuisen P.W., Eikenboom J.C., and Bertina R.M. Elevated factor VIII levels and the risk of thrombosis. Arterioscler Thromb Vasc Biol 21 (2001) 731-738
3. Korte W., Clarke S., and Lefkowitz J.B. Short activated partial thromboplastin times are related to increased thrombin generation and an increased risk for thromboembolism. Am J Clin Pathol 113 (2000) 123-127
4. Nicolaes G.A., and Dahlback B. Congenital and acquired activated protein C resistance. Semin Vasc Med 3 (2003) 33-46
5. Redondo M., Carroll V.A., Mauron T., et al. Hemostatic and fibrinolytic parameters in survivors of myocardial infarction: a low plasma level of plasmin-alpha2-antiplasmin complex is an independent predictor of coronary re-events. Blood Coag Fibr 12 (2001) 495-499
6. Ten Boekel E., Bock M., Vrielink G.J., Liem R., Hendriks H., and de Kieviet W. Detection of shortened activated partial thromboplastin times: an evaluation of different commercial reagents. Thromb Res 121 (2007) 361-367
7. Ten B.E., and Bartels P. Abnormally short activated partial thromboplastin times are related to elevated plasma levels of TAT, F1+2, D-dimer and FVIII: C. Pathophysiol Haemost Thromb 32 (2002) 137-142
8. Legnani C., Mattarozzi S., Cini M., Cosmi B., Favaretto E., and Palareti G. Abnormally short activated partial thromboplastin time values are associated with increased risk of recurrence of venous thromboembolism after oral anticoagulation withdrawal. Br J Haematol 134 (2006) 227-232
9. Tripodi A., Chantarangkul V., Martinelli I., Bucciarelli P., and Mannucci P.M. A shortened activated partial thromboplastin time is associated with the risk of venous thromboembolism. Blood 104 (2004) 3631-3634
10. Hamaad A., Sosin M.D., Blann A.D., Lip G.Y., and Mac Fadven R.J. Markers of thrombosis and hemostasis in acute coronary syndromes: relationship to increased heart rate and reduced heart rate variability. Clin Cardiol 32 (2009) 204-209